FDAnews Drug Daily Bulletin

Lycera Expands Partnership With Merck for Potential $600 Million Deal

Feb. 14, 2013
A A
Lycera doubled its sweet 2011 deal with Merck in a new agreement designed to expand on the companies’ prior relationship, which has centered on retinoic acid-related orphan receptor.
BioWorld